[D3-A3] Bioanalytical Strategy in Biopharmaceutical Development

3:30 PM - 3:55 PM JST(6:30 AM - 6:55 AM UTC)

[D3-A3-02] Strategies for Selecting Critical Reagents and Developing Analytical Methods Based on Antibody and Target Characteristics in Antibody Therapeutics Development

*Ken Ohmine¹ (1. Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd.)

Password required to view

Log in

or